Seiichi Mori

Title: Seiichi Mori: Innovator in Cancer Patient Stratification

Introduction

Seiichi Mori is a notable inventor based in Singapore, SG. He has made significant contributions to the field of cancer research, particularly in patient stratification and clinical outcomes. His innovative approach aims to enhance the treatment and management of cancer patients.

Latest Patents

Mori holds a patent for a method of generating a scheme that allows for the classification of cancer in individual patients. This invention is crucial for estimating clinical outcomes for patients suffering from various types of cancer, including epithelial ovarian cancer (EOC). The patent also outlines a method for determining whether the epithelial-mesenchymal transition score of a cancer patient can be altered by administering an EMT reversal agent, thereby increasing the patient's susceptibility to anti-cancer treatments. He has 1 patent to his name.

Career Highlights

Throughout his career, Seiichi Mori has worked with prominent institutions such as the Agency for Science, Technology and Research and the National University of Singapore. His work has been instrumental in advancing cancer research and improving patient care.

Collaborations

Mori has collaborated with esteemed colleagues in the field, including Jean Paul Thiery and Yun-Ju Ruby Huang. Their combined expertise has contributed to the development of innovative solutions in cancer treatment.

Conclusion

Seiichi Mori's contributions to cancer research through his innovative patent and collaborations highlight his commitment to improving clinical outcomes for patients. His work continues to inspire advancements in the medical field.